Internal Medicine, Hematology & Oncology · Canfield, OH
NPI
1205879491
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3695a Boardman Canfield Rd
Canfield, OH, 44406
Phone (330) 533-3040
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.9M
322,950 services
Medicare patients, 2024
730
Average age 75
Drug cost, 2024
$30.6M
7,240 prescriptions
Company payments, 2025
$3,841
From 55 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Antoine E Chahine was code J1439 (injection, ferric carboxymaltose, 1 mg), 50,250 times for 36 patients. In total Antoine E Chahine billed 322,950 services in 133 codes, and Medicare paid $3.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 50,250 | 36 | $0.87 | $44K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 34,900 | 49 | $1.53 | $53K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 24,600 | 15 | $36.86 | $907K |
| J0897 Injection, denosumab, 1 mg | Office | 18,241 | 41 | $11.94 | $218K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 9,351 | 11 | $8.40 | $79K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 6,072 | 15 | $14.72 | $89K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,239 | 43 | $0.09 | $290 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,400 | 18 | $15.16 | $36K |
| 36415 Venipuncture Blood Collection | Office | 1,814 | 435 | $8.64 | $16K |
| 85025 Blood Count | Office | 1,777 | 430 | $7.60 | $14K |
| 80053 Clinical Chemistry | Office | 1,674 | 427 | $10.34 | $17K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,540 | 20 | $0.71 | $1,086 |
| 99213 Office E&M - Established | Office | 1,382 | 401 | $64.25 | $89K |
| 96375 Injection Administration | Office | 1,014 | 64 | $11.43 | $12K |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 972 | 14 | $0.00 | $0.8 |
By year: 2022 $3.6M for 290,018 services; 2023 $3.5M for 249,052 services; 2024 $3.9M for 322,950 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,814 | 435 | $8.64 | $16K |
| 85025 Blood Count | 1,777 | 430 | $7.60 | $14K |
| 80053 Clinical Chemistry | 1,674 | 427 | $10.34 | $17K |
| 82378 Clinical Chemistry | 459 | 186 | $18.58 | $8,528 |
| 82728 Clinical Chemistry | 395 | 161 | $13.30 | $5,252 |
| 83540 Clinical Chemistry | 394 | 161 | $6.31 | $2,486 |
| 84466 Clinical Chemistry | 391 | 159 | $12.44 | $4,864 |
| 86300 Immunoassay | 327 | 129 | $20.39 | $6,668 |
| 82784 Immunoassay | 273 | 45 | $9.11 | $2,488 |
| 82607 Clinical Chemistry | 185 | 104 | $14.78 | $2,734 |
Medicare prescription drug claims, 2024
In 2024, the drug Antoine E Chahine prescribed most often to Medicare patients was Prednisone, with 286 prescriptions and refills. In total Antoine E Chahine wrote 7,240 Medicare prescriptions that cost $30.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 286 | 392 | 76 | $1,527 |
| Aranesp Darbepoetin Alfa In Polysorbat | 220 | 220 | 53 | $329K |
| Gabapentin Generic | 188 | 278 | 51 | $2,289 |
| Neulasta Onpro Pegfilgrastim | 184 | 184 | 42 | $1.1M |
| Potassium Chloride Generic | 165 | 185 | 57 | $2,214 |
| Acyclovir Generic | 162 | 326 | 54 | $3,306 |
| Anastrozole Generic | 159 | 434 | 46 | $3,453 |
| Xgeva Denosumab | 152 | 152 | 21 | $485K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 150 | 150 | 28 | $3,630 |
| Calquence Acalabrutinib Maleate | 146 | 146 | 14 | $2.1M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 145 | 147 | 23 | $3,839 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 141 | 141 | Under 11 | $1.1M |
| Imbruvica Ibrutinib | 140 | 140 | 12 | $2.2M |
| Hydroxyurea Generic | 136 | 312 | 35 | $2,892 |
| Lorazepam Generic | 130 | 174 | 27 | $593 |
Brand drugs: 3,082 claims; generic drugs: 4,158 claims; opioid claims: 544.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antoine E Chahine $3,841 ($3,841 in general payments such as food, travel and fees) from 55 companies. The largest payer was Daiichi Sankyo Inc. with $219.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 11 | $219 |
| Merck Sharp & Dohme LLC MRK | 9 | $215 |
| Abbvie Inc. ABBV | 11 | $211 |
| Janssen Biotech, Inc. JNJ | 10 | $206 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $206 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $167 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $159 |
| Lilly USA, LLC LLY | 2 | $154 |
| Exelixis Inc. EXEL | 2 | $144 |
| Genzyme Corporation SNY | 5 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.